Siplizumab: A Deep Examination into MEDI-507 and 288392-69-8 Siplizumab, previously known as MEDI-507 and bearing the chemical designation 288392-69-8, represents a novel monoclonal designed to selectively target the CD25 receptor, a vital element of the IL-2 system. Its development foc